Diagnostic Information as a Commodity
Horton A. Johnson
In estimating the cost-effectiveness of diagnostic procedures, it is helpful to treat diagnostic information as a commodity with a unit price. The amount of useful information provided by a test result can be measured in binary units (bits), and the unit price of the information produced by the test result can be expressed in dollars per bit in much the same way that the price of gold is given in dollars per ounce. This allows comparison of the unit prices of various diagnostic tests, examination of the effect of multiple testing, and calculation of the most cost-effective conditions for screening tests.
Indexing Terms: economics of laborato,y operation/information theoiy/predictive value
In this information age, no one is more deeply involved in the production and purchase of information than those involved in healthcare. Yet, it is astonishing to consider that, unlike any other commodity, billions of dollars worth of diagnostic information is bought and sold each year without ever being measured.
The results of a perfectly valid clinical observation, imaging procedure, or laboratory test may provide much or little useful diagnostic information, depending on the clinical context. It can easily happen, and it often does, that a well-executed diagnostic test with great accuracy and reproducibility may produce a result that provides little or no useful clinical information, e.g., when the test is irrelevant or redundant. Simply dealing in numbers of diagnostic procedures is like quoting numbers of barrels of oil produced without ever defining the size of a barrel.
Measuring the Clinical Value of an Information-Gathering
Procedure Diagnostic information is produced by the physician or laboratorian and is purchased by the patient or his or her payor. All three, laboratorian, physician, and payor, wish to provide or obtain the greatest possible value to the patient for the least cost. In most cases, the cost-benefit ratio of information-gathering procedures can be estimated only vaguely. The costs of the history, the physical examination, and the necessary imaging, physiological, and laboratory testing can be fairly well established in dollar amounts, but other cost factors, such as patient risk and anxiety, must also be factored in. The benefit of an information-gathering procedure should be measured in terms of patient outcome, such as increase in longevity or quality of life. Such data are seldom available.
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A simpler, although less comprehensive, cost-benefit ratio can be defined by comparing the dollar cost of an information-gathering procedure with the amount of useful information generated by that procedure-the assumption being that clinically useful information will in, a general way, improve patient outcome. Vecchio (1) . The predictive value of a test or observation is a conditional probability, i.e., the probability of a given diagnosis, given the condition that the test is positive. The calculus of conditional probability is often called Bayesian probability after its inventor, the Reverend Thomas Bayes (2), an 18th-century nonconformist minister who, ironically, cautioned not to take mathematics too seriously (3). The Bayesian calculus allows the calculation of the predictive value of a test from its sensitivity, specificity, and pretest probability of the disease.
The predictive value is a measure of the posttest probability of a given disease, but it does not, despite its name, measure the value of the test. A high predictive value of a test may suggest that the test was worthwhile, but if the pretest probability was nearly as high, then the test was of little value. The value of a test must be measured by the degree to which the test advances the diagnostic process. The value of a test thus must be based on a comparison of the posttest The test has 90% sensitIvity and specificity.As the usefulness of the test decreases, its predictive value increases.
PRE-TEST PROBABILITY
(1)
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Take the case of a patient who, after history and physical examination, has, in the mind of the clinician, a 50-50 chance of having had a recent acute myocardial infarction (prevalence, 0.5). The results for the electrocardiogram (EKG) and creatine kinase-myocardial fraction (CK-MB) are positive.' (The positive cutoff value for CK-MB concentration and the criteria for a "positive" EKG must be defined clinically.) What is the diagnostic value of an additional measurement of aspartate aminotransferase (AST)? In this situation, given its sensitivity and specfficity of 0.98 and 0.71 [again as clinically defined (4)], the predictive value of an above-normal AST value will be 99.9%. That, on the face of it, sounds worthwhile; if the test is positive, one can be 99.9% certain of the diagnosis. But how far has the test advanced the diagnostic process? One must consider that the pretest probability of an acute myocardial infarct, given a positive EKG and CK-MB, was already 99.8% (5) . An increased AST would increase the probability of the diagnosis by only 0.1% and so is probably not worth doing. Its diagnostic value is practically nil, despite its high predictive value.
A measure of test value must somehow compare the posttest probability of a disease with the pretest probability of that disease. Because successive probabilities are multiplicative, the ratio of the two offers an appropriate comparison. If the posttest probability is nearly the same as the pretest probability, the ratio will be nearly unity, and the diagnostic value of the test will be nearly zero. This is shown in Fig. 1 , where, as the pretest probability increases, the predictive value also increases, approaching unity (100%). At the same time, the ratio of posttest probability to pretest probability decreases, approaching unity. A ratio of unity means that the test has not changed the probability of the diagnosis and is of no value. Measured against the pretest probability of a disease, when the predictive value of any test reaches its maximum (100%), the diagnostic value of that test is minimal.
Why the Logarithm of the Ratio of Posttest to Pretest Probability Is a Useful Measure of Test Value
A useful measure of test value should be such that when the ratio of post-to pretest probability is equal to one, the test value is zero. Because the logarithm of one is zero, it is convenient to measure the test value as fPosttest probablility Diagnostic value = log I \ Pretest probability This measure will give a value of zero if the test has not advanced the probability of the disease, i.e., if the ratio of post-to pretest probability is one. Conveniently, it is also the measure of diagnostic information (7). Using the statistical mechanical definition of entropy, which says that the amount of entropy in a system is proportional to the logarithm of the probability of a given microstate, Szilard showed that a decrease in entropy (an increase in information) is equal to the difference between the final and initial entropies, which then must be proportional to the logarithm of the ratio of the probabilities of the microstates.
Thus, in classical information theory, the change in information content of a system or a message is proportional to the logarithm of the ratio of its a posteriori to its a priori probabilities.
A diagnostic test produces a quantity of information proportional to the logarithm of the ratio of posttest to pretest probability of the disease in question.
Expressing the Informational Value of a Diagnostic Test in Binary Units (Bits)
What about units of information measurement? Szilard, using the natural logarithm and Planck's constant as the proportionality constant, measured information in entropy units. It is more useful to use the binary unit or bit, first proposed by the mathematician Norbert Wiener (8) . Results are given in bits of information if the logarithm is taken to the base two. In other words, a laboratory test or clinical observation provides one bit of information if it doubles the probability of a given disease; i.e., if the ratio of posttest to pretest probability is two, the logarithm to the base two of two gives one bit of information: log2 2 = 1. This is a fundamental idea of information theory. One must be aware, however, that information has been highly developed for applications in communications engineering, and there are dangers in making direct applications of information theory to the gathering of diagnostic information.
It has been useful in evaluating clinical testing (9) , but misinterpretation of the Shannon-Wiener function, a centerpiece of information theory, has led to gross errors in calculations of information provided by diagnostic tests (10) . Therefore, for the purposes of this study, it seems wise to develop only those ideas of information theory necessary to my thesis and to develop them from first principles.
In summary, calculation of the informational value of a test result requires the following data: (a) the pretest probability of the disease in question in a given patient; and (b) the test's sensitivity and specfficity, or its likelihood ratio, for the disease in question. Because, strictly speaking, information can be useful or useless, note that the information measured here is "useful" information, meaning that the information leads toward a diagnosis that is useful in improving the patient outcome.
From the posttest probability (predictive value), calculated from sensitivity and specificity, the amount of useful information in bits is -1 (Posttest probability -og2 Pretest probability
Using the likelihood ratio, R, and pretest probability, p.
Returning to the clinical example, according to Eq. 2, the EKG and CK-MB have provided 0.998 I = log2 0 50 = 0.996 bits of information Adding an AST to the panel will add only log2 (0.999/ 0.998) = 0.002 bits of useful information.
In deciding whether to add the AST to the test panel, a simplified cost-benefit ratio can be examined. Consider the cost per test. If, for example, the EKG and CK-MB together cost $100 and the AST costs just $10, the added cost of an AST may seem trivial. However, one is not buying tests; one is buying clinicallyuseful information.
Considering the price of information, the EKG and CK-MB together cost .$ 100 per bit, but a positive AST result will cost $5000 per bit. That realization should influence the decision.
An unexpected negative AST should provide more information than an expected positive result. The predictive value of a negative AST result can be calculated by using the complements of sensitivity and specificity. In the case above, a negative result gives a predictive value (posttest probability) of 0.934. The information provided will be
bits
Negative information is perfectly valid information. It decreases the probability of the diagnosis, which is useful information.
The meaning of the negative sign is that the result decreases our certainty about the disease (11) . In this case, the negative result provides little information, because with a high pretest probability of disease, the probability of a false-negative result becomes large. The cost of this negative information is $100 per bit. Because a positive result is much more likely, one is much more apt to be paying $5000 per bit for the test result, and the test is probably not worth doing. (12) . Figure 3 shows the amount of information provided by a positive abdominal ultrasound after a positive serum (2) lipase. Given the high preultrasound (postlipase) probability of acute pancreatitis, the increase in probability achieved by the ultrasound is small, and the test cost per bit is high.
Sequential Testing
If the tests are done in reverse order, the informa- (3) tional value of the ultrasound will be greater and that of the lipase will be less. However, the overall amount of information contributed by the two tests will not change.
The Mean Amount of Information to Be Expected from a Screening Test
Up to this point, the information provided by either a positive or negative test result has been considered.
What is the mean amount of useful information pro- 
where is the information provided by a positive result, P,05 is the probability of a positive result, 'neg the information provided by a negative result, and Pneg is the probability of a negative result. Figure 4 shows the mean information yield for various pretest probabilities (prevalences). The information yield must decrease to zero at each extreme, because if the prevalence is zero, a negative test result will give no useful information, and all of the positive results will be false and give no information. If the prevalence is 100%, a positive result will give no information, and all negatives will be false and give no information. This curve is for a test with equal sensitivity and specificity. Disparate values of sensitivity and specificity do little to skew the curve. The highest information yield per test will be obtained from a test population in which the pretest probability, or prevalence, of the disease in question is close to 50%.
In conclusion, there are situations in which it would be useful to be able to estimate the cost-benefit of a diagnostic test. Given that the benefit in terms of patient outcome is difficult to quantify, a second-best measurement of benefit is the amount of clinically 
it should be measured.
